• 1
    Kwoh DY, Davis GR, Whitfield KM, Chappelle HL, DiMichele LJ, Gingeras TR. Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format. Proc Natl Acad Sci USA1989; 86: 11731177.
  • 2
    Edelstein PH, Edelstein MA. Evaluation of the Merifluor-Legionella immunofluorescent reagent for identifying and detecting 21 Legionella species. J Clin Microbiol1989; 27: 24552458.
  • 3
    Picken RN. Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol1992; 30: 99114.
  • 4
    Ohori H, Kanno A, Nagatsuka Y et al. An antigen/antibody system specific for an epidemic non-A, non-B hepatitis in patients of a cardiovascular surgical unit. J Med Virol1983; 12: 161178.
  • 5
    Rickard CM, McCann D, Munnings J, McGrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med2010; 8: 53.
  • 6
    Metcalfe TA. Development of novel IVD assays: a manufacturer’s perspective. Scand J Clin Lab Invest Suppl2010; 242: 2326.
  • 7
    Kayaba H. Rapid detection tests for viruses available in pediatric clinics. Rinsho Byori2002; 50: 10471054.
  • 8
    Sosnowski R, Heller MJ, Tu E, Forster AH, Radtkey R. Active microelectronic array system for DNA hybridization, genotyping and pharmacogenomic applications. Psychiatr Genet2002; 12: 181192.
  • 9
    Brassard D, Clime L, Li K et al. 3D thermoplastic elastomer microfluidic devices for biological probe immobilization. Lab Chip2011; 23: 40994107.
  • 10
    Zhao W, Brook MA, Yingfu L. Design of gold nanoparticle based colorimetric biosensing assays. ChemBioChem, 2008; 9: 23632371.
  • 11
    Bissonnette L, Bergeron MG. Next revolution in the molecular theranostics of infectious diseases: micro-fabricated systems for personalized medicine. Expert Rev Mol Diagn2006; 6: 433450.
  • 12
    Zhao W, Karp JM, Ferrari M, Serda R. Bioengineering nanotechnology: towards the clinic. Nanotechnology2011; 22: 490201.
  • 13
    Munson E, Kramme T, Culver A, Hryciuk JE, Schell RF. Cost-effective modification of a commercial PCR assay for detection of methicillin-resistant or -susceptible Staphylococcus aureus in positive blood cultures. J Clin Microbiol2010; 48: 14081412.
  • 14
  • 15
    Villars F, Pariente JL, Conort P. CE marking for medical devices. Prog Urol2005; 15: 985991.
  • 16
    Donawa M. Medical device directive: preparing for the amendments. Med Device Technol2000; 11: 4045.
  • 17
    Katawa G, Kpotsra A, Karou DS, Eklou M, Tayi KE, de Souza C. Contribution to the establishment of quality assurance in five medical microbiology departments in Togo. Bull Soc Pathol Exot2011; 104: 2024.
  • 18
  • 19
    Bremond J, Plebani M. IVD industry role for quality and accreditation in medical laboratories. Clin Chim Acta2001; 309: 167171.
  • 20
    Unemo M, Rossouw A, James V, Jenkins C. Can the Swedish new variant of Chlamydia trachomatis (nvCT) be detected by UK NEQAS participants from seventeen European countries and five additional countries/regions in 2009?Euro Surveill2009; 14: 19206.
  • 21
    Emmadi R, Boonyaratanakornkit JB, Selvarangan R et al. Molecular methods and platforms for infectious diseases testing: a review of FDA-approved and cleared assays. J Mol Diagn2011; 13: 583604.
  • 22
    Renub Research. Global molecular diagnostic market: opportunities and future forecast. Rosewell, GA. 8/2009, RE-1503.
  • 23
    Nishino HT, Tambouret RH, Wilbur DC. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology. Cancer Cytopathol2011; 119: 219227.
  • 24
    Fredlund H, Falk L, Jurstrand M, Unemo M. Molecular genetic methods for diagnosis and characterisation of Chlamydia trachomatis and Neisseria gonorrhoeae: impact on epidemiological surveillance and interventions. APMIS2004; 112: 771784.
  • 25
    Cobb BR, Vaks JE, Do T, Vilchez RA. Evolution in the sensitivity of quantitative HIV-1 viral load tests. J Clin Virol2011; 52 (suppl): S77S82.
  • 26
    Jap A, Chee SP. Viral anterior uveitis. Curr Opin Ophthalmol2011; 22: 483488.
  • 27
    Endimiani A, Hujer KM, Hujer AM et al. Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?Clin Infect Dis2011; 52 (suppl): S373S383.
  • 28
  • 29
    Infectious Diseases Society of America. An unmet medical need: rapid molecular diagnostics tests for respiratory tract infections. Clin Infect Dis2011; 52 (suppl): S384S395.
  • 30
    Platts-Mills JA, Operario DJ, Houpt ER. Molecular diagnosis of diarrhea: current status and future potential. Curr Infect Dis Rep2012; 14: 4146.
  • 31
    de Pagter PJ, Schuurman R, de Vos NM, Mackay W, van Loon AM. Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. J Clin Microbiol2010; 48: 25362540.
  • 32
    Pandit A, Mackay WG, Steel C, van Loon AM, Schuurman R. HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme. J Clin Virol2008; 43: 401406.
  • 33
    Mackay WG, van Loon AM, Niedrig M, Meijer A, Lina B, Niesters HG. Molecular detection and typing of influenza viruses: are we ready for an influenza pandemic?J Clin Virol2008; 42: 194197.
  • 34
    Barbi M, MacKay WG, Binda S, van Loon AM. External quality assessment of cytomegalovirus DNA detection on dried blood spots. BMC Microbiol2008; 8: 2.
  • 35
    Staines HJ, Garcia-Fernandez L, Pogothata R, Wallace PS, MacKay WG, Van Loon AM. Monitoring performance of nucleic acid based diagnostic measurement system users by EQA. Accred Qual Assur2009; 14: 243252.
  • 36
    Loens K, Mackay WG, Scott C, Goossens H, Wallace P, Ieven M. A multicenter pilot external quality assessment program to assess the quality of molecular detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae. J Microbiol Methods2010; 82: 131135.
  • 37
    Loens K, Beck T, Ursi D et al. Evaluation of different nucleic acid amplification techniques for the detection of M. pneumoniae, C. pneumoniae and Legionella spp. in respiratory specimens from patients with community-acquired pneumonia. J Microbiol Methods2008; 73: 257262.
  • 38
    Loens K, van Loon AM, Coenjaerts F et al. Performance of different mono- and multiplex nucleic acid amplification tests on a multipathogen external quality assessment panel. J Clin Microbiol2012; 50: 977987.
  • 39
    Michel CE, Saison FG, Joshi H, Mahilum-Tapay LM, Lee HH. Pitfalls of internet-accessible diagnostic tests: inadequate performance of a CE-marked Chlamydia test for home use. Sex Transm Infect2009; 85: 187189.
  • 40
    Gaydos CA. Can we climb out of the ‘pit’ of poorly performing rapid diagnostic tests for chlamydia?Sex Transm Infect2009; 85: 158.
  • 41
    Dannaoui E, Schwarz P, Slany M et al. Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation. J Clin Microbiol2010; 48: 20432046.
  • 42
    Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V. Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices. J Obstet Gynaecol2009; 29: 583589.
  • 43
  • 44
  • 45
  • 46
  • 47
    Sípová H, Zhang S, Dudley AM, Galas D, Wang K, Homola J. Surface plasmon resonance biosensor for rapid label-free detection of microribonucleic acid at sub-femtomole level. Anal Chem2010; 82: 1011010115.
  • 48
    Raeymaekers M, Bakkus M, Boone E et al. Reflections and proposals to assure quality in molecular diagnostics. Acta Clin Belg2011; 66: 3341.
  • 49
    Weissfeld AS. Streamlined quality control of commercial microbial identification systems. Clin Microbiol Newslett2011; 33: 3537.
  • 50
    Grys TE. Developing a quality system for quantitative laboratory-developed tests. Clin Microbiol Newslett2011; 33: 179185.